Related Experiment Video
Updated: Jun 14, 2025

Author Spotlight: Preservation of Bioenergetic Parameters in Peripheral Blood Mononuclear Cells After Cryopreservation
Published on: October 20, 2023
Cryo-EM evidence for a common factor in Alzheimer's and other neurodegenerations
1Neuropathology, Cellular Pathology, South West London Pathology, St George's Hospital, St George's University Hospitals NHS Foundation Trust, London, UK and Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Abstract:
In the last seven years, cryo-EM maps of neuropathological fibrils from Alzheimer's disease and other neurodegenerations have been released by various authors1-44. The first publication11 noted an unknown component coordinating with lysine residues in the protein, a finding recapitulated in many succeeding studies. Previous authors have emphasized difficulties in analysing this component12,20,28,33,43,45, but current findings, using powerful visualisation software UCSF ChimeraX46 on all publicly available maps1-44, indicate that the issue is tractable. Lysine-coordinating extra densities have common features, including a Y-shaped substructure, suggestive of a molecular factor in common, in neuropathological fibrils from a wide range of neurodegenerations and involving misfolded proteins beta-amyloid10,35, alpha-synuclein27,37,39,41, prion protein17, tau1,5,7,8,11,12,15,16,19,22-26,29-33,35,43 and transmembrane protein 106B5,9,18,20,24,28,36,44. A similar component, albeit in non-lysine environments, was found in neuropathological fibrils involving TAR DNA-binding protein 432,3 and TATA-binding protein-associated factor 1536. The results suggest the existence of a common molecular factor, a predominantly anionic polymer, linking these diseases and raising the possibility of a unitary basis for Alzheimer's and other neurodegenerations. Based on evidence here, RNA is a feasible candidate for this putative common factor. Such findings raise the possibility of new diagnostic tests and treatments for these devastating diseases in the future.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cryo-electron Microscopy
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

